Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Alzheimer's and Parkinson's cause similar cognitive symptoms, but show opposing patterns on MRI
This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.
American College of Cardiology announces late-breaking clinical trials for ACC.25
The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.
New directions and trends in interventional cardiology
Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business.
Valve durability after TAVR: Cardiologists track how deterioration influences outcomes
Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.
AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD
Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

As of Monday, about 23,000 individuals had registered for the world's largest medical imaging conference compared to 51,800 in 2019.

Researchers focused on rates of venous thromboembolism among COVID-19 patients at their own health system, sharing their work in JAMA Network Open.

The full analysis was published in Circulation: Heart Failure.

The Disrupt BTK II study will include 250 patients overall.